la cirujana Naia Uribe-Etxebarria ha presentado su tesis doctoral en la UPV/EHU. Esta tesis se basa en la utilización de un marcador radioactivo, que ayuda a conocer el posible camino que tomaría el cancer de pulmón de un paciente para extenderse por su organismo. La utilización de ese isótopo radioactivo ayuda a conocer cuál es el ganglio a través del que el cancer va a intentar difundirse, y eso ayuda a ser mucho más eficaz en la cirugia.

First Science -10/6/2011 – Gran Bretaña

Following the traces of lung cancer


Surgeon Naia Uribe-Etxebarria has used a radioactive substance which, injected into a lung tumour, enables the detection of the path that the carcinoma intends to take in order to propagate itself. Concretely she applied technetium 99 in resectable non-small cell lung cancers (NSCLC) at an early stage (I or II), and in an intraoperative manner. Thanks to this, she detected with precision the sentinel node (SNOL); the primary node or ganglion of cells to receive lymphatic drainage from the tumour and, thus, most probably the one that will be affected by the tumour and give rise to its propagation. Her PhD thesis, defended at the University of the Basque Country (UPV/EHU), is entitled Utility of the intraoperative study of the sentinel node with technetium 99 for the staging of non-small cell lung carcinoma.
(sigue)
anuncio-productos-basque-728x85-2